Print | Email Page

Funds managed by Invesco Asset Management Limited participate in $80 million PIPE investment in Evofem Biosciences

June 2019

Jones Day advised funds managed by Invesco Asset Management Limited in their participation in an $80 million PIPE investment in Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.

For additional information about this matter, please contact: Alexander A. Gendzier, Joshua Berick

Client(s): Invesco Asset Management Limited
Office(s): New York, Chicago